You are here: Industry Insights > Qynapse

News List

Qynapse to present clinical results of QyScore® for Alzheimer's Disease and Multiple Sclerosis at the 7th Congress of the European Academy of Neurology prnasia
June 16, 2021
QYNAPSE Inc., a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, today announced it will present clinical data on QyScore® for Alzheimer's disease and multiple sclerosis at the 7th Congress of ...
QYNAPSE Joins Decentralized Trials & Research Alliance (DTRA) To Democratize And Accelerate Clinical Trials prnewswire
December 31, 2020
QYNAPSE Inc. joins a historic alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
QYNAPSE (France) and TRUE POSITIVE MEDICAL DEVICES (Canada) are partnering to provide the most advanced AI platform for brain diseases prnasia
October 14, 2020
QYNAPSE SAS, a French medical technology company, announces the acquisition of the Canadian company TRUE POSITIVE MEDICAL DEVICES Inc. (TPMD), a spin-off from the universities of McGill and Laval.